A MULTI-CENTER, OPEN-LABEL, ASCENDING, MULTIPLE ORAL DOSE, SAFETY, TOLERANCE AND PHARMACOKINETIC STUDY OF 3'-DEOXY-3'-FLUOROTHYMIDINE (FLT) IN PATIENTS WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) OR AIDS-RELATED COMPLEX (ARC):